296 related articles for article (PubMed ID: 30772440)
21. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
Mott JH; Livsey JE; Logue JP
Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
[TBL] [Abstract][Full Text] [Related]
22. Pelvic Ewing sarcomas. Three-dimensional conformal vs. intensity-modulated radiotherapy.
Mounessi FS; Lehrich P; Haverkamp U; Willich N; Bölling T; Eich HT
Strahlenther Onkol; 2013 Apr; 189(4):308-14. PubMed ID: 23443613
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
[TBL] [Abstract][Full Text] [Related]
24. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer.
Patel RR; Orton N; Tomé WA; Chappell R; Ritter MA
Radiother Oncol; 2003 Jun; 67(3):285-94. PubMed ID: 12865176
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
[TBL] [Abstract][Full Text] [Related]
26. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
[TBL] [Abstract][Full Text] [Related]
27. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
Bauman G; Gete E; Chen JZ; Wong E
Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
[TBL] [Abstract][Full Text] [Related]
29. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
Moore KL; Schmidt R; Moiseenko V; Olsen LA; Tan J; Xiao Y; Galvin J; Pugh S; Seider MJ; Dicker AP; Bosch W; Michalski J; Mutic S
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):228-35. PubMed ID: 25847605
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
31. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
32. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
Reddy NM; Nori D; Chang H; Lange CS; Ravi A
Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
[TBL] [Abstract][Full Text] [Related]
33. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
[TBL] [Abstract][Full Text] [Related]
35. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
36. Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays.
Hayashi A; Shibamoto Y; Hattori Y; Tamura T; Iwabuchi M; Otsuka S; Sugie C; Yanagi T
J Radiat Res; 2015 Mar; 56(2):338-45. PubMed ID: 25609741
[TBL] [Abstract][Full Text] [Related]
37. Rectal dose reduction with IMRT for prostate radiotherapy.
Hardcastle N; Davies A; Foo K; Miller A; Metcalfe PE
J Med Imaging Radiat Oncol; 2010 Jun; 54(3):235-48. PubMed ID: 20598012
[TBL] [Abstract][Full Text] [Related]
38. Rapid Arc, helical tomotherapy, sliding window intensity modulated radiotherapy and three dimensional conformal radiation for localized prostate cancer: a dosimetric comparison.
Kinhikar RA; Pawar AB; Mahantshetty U; Murthy V; Dheshpande DD; Shrivastava SK
J Cancer Res Ther; 2014; 10(3):575-82. PubMed ID: 25313742
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
[TBL] [Abstract][Full Text] [Related]
40. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.
Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
